Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Levemir® Label Update
Levemir® (insulin detemir [rDNA origin] injection) has been approved for use in combination with metformin and a GLP-1 receptor agonist. In the study, when Levemir® once daily added on to metformin + Victoza, 50% of patients reached A1c goal <7%.